Author
Listed:
- Marc H. G. P. Raaijmakers
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Siddhartha Mukherjee
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Cancer Center, Massachusetts General Hospital,
Harvard University
Harvard Stem Cell Institute,)
- Shangqin Guo
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Siyi Zhang
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Tatsuya Kobayashi
(Endocrine Unit, Massachusetts General Hospital and Harvard Medical School,)
- Jesse A. Schoonmaker
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Benjamin L. Ebert
(Broad Institute, Cambridge, Massachusetts 02138, USA
Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA)
- Fatima Al-Shahrour
(Broad Institute, Cambridge, Massachusetts 02138, USA
Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA)
- Robert P. Hasserjian
(Massachusetts General Hospital and Harvard Medical School)
- Edward O. Scadden
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Zinmar Aung
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Marc Matza
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Harvard University
Harvard Stem Cell Institute,)
- Matthias Merkenschlager
(Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, Du Cane Road, London W12 0NN, UK)
- Charles Lin
(Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA)
- Johanna M. Rommens
(Program in Genetics and Genome Biology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5S 1A8, Canada)
- David. T. Scadden
(Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN, Room 4265A, 185 Cambridge Street,
Cancer Center, Massachusetts General Hospital,
Harvard University
Harvard Stem Cell Institute,)
Abstract
Mesenchymal cells contribute to the ‘stroma’ of most normal and malignant tissues, with specific mesenchymal cells participating in the regulatory niches of stem cells. By examining how mesenchymal osteolineage cells modulate haematopoiesis, here we show that deletion of Dicer1 specifically in mouse osteoprogenitors, but not in mature osteoblasts, disrupts the integrity of haematopoiesis. Myelodysplasia resulted and acute myelogenous leukaemia emerged that had acquired several genetic abnormalities while having intact Dicer1. Examining gene expression altered in osteoprogenitors as a result of Dicer1 deletion showed reduced expression of Sbds, the gene mutated in Schwachman–Bodian–Diamond syndrome—a human bone marrow failure and leukaemia pre-disposition condition. Deletion of Sbds in mouse osteoprogenitors induced bone marrow dysfunction with myelodysplasia. Therefore, perturbation of specific mesenchymal subsets of stromal cells can disorder differentiation, proliferation and apoptosis of heterologous cells, and disrupt tissue homeostasis. Furthermore, primary stromal dysfunction can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis.
Suggested Citation
Marc H. G. P. Raaijmakers & Siddhartha Mukherjee & Shangqin Guo & Siyi Zhang & Tatsuya Kobayashi & Jesse A. Schoonmaker & Benjamin L. Ebert & Fatima Al-Shahrour & Robert P. Hasserjian & Edward O. Scad, 2010.
"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia,"
Nature, Nature, vol. 464(7290), pages 852-857, April.
Handle:
RePEc:nat:nature:v:464:y:2010:i:7290:d:10.1038_nature08851
DOI: 10.1038/nature08851
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:464:y:2010:i:7290:d:10.1038_nature08851. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.